Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sales of long-acting immunosuppressants for non-infectious uveitis to touch $357 mn by 2029:…
While more chronic and recurrent uveitis patients will experience relief from treatment with long-acting immunosuppressants, a key…
ICMR-NICED submits proposal to DBT for research on oral COVID-19 vaccine
It will take around five to six years to develop the oral vaccine in a laboratory, said Shanta Dutta, Director, ICMR-NICED
Ignite Life Science Foundation announces grant for developing mRNA vaccine technology
A grant of three years was awarded to the Indian Institute of Science (Bangalore) and the Translational Health Science and…
We will look at further expanding our footprint in India by relying on innovative new products
Shripad Joshi, President - India and South Asia, PerkinElmer talks about his company's plans for the India market and informs that…
Study finds rise in antibiotic misuse in India during COVID first wave
The researchers estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses…
PharmEasy-Thyrocare deal milestone for e-pharmacy sector
No longer part of the 'upstart start ups' brigade, it is high time e-pharmacies get their own regulations
Panacea Biotec gets license to manufacture Sputnik V vaccine at Baddi, Himachal Pradesh
Sputnik V was registered in India under the emergency use authorisation procedure on April 12, 2021, and vaccination against…
Topical JAK inhibitors becoming a major force in atopic dermatitis space: GlobalData
An increasing number of JAK agents are filling the early and late-stage pipeline. Of the 98 pipeline agents, eight are JAKs – with…
Government allots funds from PMCares for new lab in Hyderabad to test vaccines
The laboratory in Hyderabad is expected to commence operations in the next one month
EQT Private Equity and Goldman Sachs to acquire Parexel
The deal is worth $8.5 billion